Phase II Study in Collaboration with the Southwest Oncology Group of Gemcitabine and Cisplatin for the treatment of Pleural Mesothelioma. Unresectable malignant mesothelioma of the pleura. No prior chemotherapy . No prior radiation therapy Patients will be treated on an outpatient basis with both intravenous Gemcitabine and Cisplatin. Phase II single institution study of Gemcitabine and Taxol for the treatment of Malignant Mesothelioma.
Trial is under development at the present time.
Nonresectable malignant mesothelioma either of the pleura or peritoneum. Prior chemotherapy is permitted. Patients will be treated with both Taxol and Gemcitabine intravenously.